Nautilus Biotechnology (NAUT) Change in Acquisitions & Divestments (2020 - 2026)

Nautilus Biotechnology has disclosed Change in Acquisitions & Divestments across 7 years of filings, most recently posting $25.8 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $25.8 million, down 3.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $108.2 million (down 31.99% YoY), and the FY2025 annual result was $109.0 million, down 29.87% from the prior year.
• Change in Acquisitions & Divestments came in at $25.8 million for Q1 2026 at Nautilus Biotechnology, down from $34.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $67.0 million in Q2 2022 to a low of $14.2 million in Q1 2023.
• The 5-year median for Change in Acquisitions & Divestments is $26.6 million (2025), against an average of $30.9 million.
• Across the five-year window, Change in Acquisitions & Divestments jumped 318.75% in 2022 and tumbled 73.13% in 2023, its largest moves.
• Nautilus Biotechnology's Change in Acquisitions & Divestments stood at $21.1 million in 2022, then fell by 3.55% to $20.3 million in 2023, then soared by 219.41% to $65.0 million in 2024, then plunged by 46.54% to $34.8 million in 2025, then slipped by 25.74% to $25.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $25.8 million (Q1 2026), $34.8 million (Q4 2025), and $28.4 million (Q3 2025), per Business Quant data.